Viromed Medical AG has partnered with Lang Life Sciences GmbH to distribute its ViroCAP cold plasma device in veterinary medicine across Germany, Austria, and Switzerland.
A New Frontier for Cold Plasma
- AMAMUS Vet, Lang’s veterinary platform, gains exclusive rights to market the ViroCAP VET for treating skin infections, eczema, allergies, and bite wounds in animals.
- Lang Life Sciences has committed to purchasing 1,000 units in the first 12 months, with deliveries beginning end of August.
- The goal: minimize antibiotic use and provide pain-free, contactless therapy for animals.
Viromed’s entry into the veterinary space opens doors to future expansion into the U.S. market, supported by a growing demand for animal-friendly, non-invasive treatments.
Follow MEDWIRE.AI for veterinary MedTech breakthroughs.
